48 results on '"Witteles, Ronald M."'
Search Results
2. Prevalence, mutational spectrum and clinical implications of clonal hematopoiesis of indeterminate potential in plasma cell dyscrasias
3. Improvements in Efficacy Measures With Tafamidis in the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial
4. Late-Onset Immunotherapy-Induced Myocarditis 2 Years After Checkpoint Inhibitor Initiation
5. The Role of Single-Cell Profiling and Deep Immunophenotyping in Understanding Immune Therapy Cardiotoxicity
6. Pharmacovigilance Analysis of Cardiac Toxicities Associated With Targeted Therapies for Metastatic NSCLC
7. Cardiac Transplantation and Mechanical Circulatory Support in Amyloidosis: JACC: CardioOncology Primer
8. Racial and Ethnic Disparities in Cardio-Oncology: A Call to Action
9. Outcomes in Patients With Cardiac Amyloidosis Undergoing Heart Transplantation
10. Organ responses with daratumumab therapy in previously treated AL amyloidosis
11. A Changing Landscape of Mortality for Systemic Light Chain Amyloidosis
12. Diagnosis and Treatment of Cardiac Amyloidosis Related to Plasma Cell Dyscrasias
13. Increase in Blood Pressure Associated With Tyrosine Kinase Inhibitors Targeting Vascular Endothelial Growth Factor
14. AL Amyloidosis for the Cardiologist and Oncologist: Epidemiology, Diagnosis, and Management
15. Screening for Transthyretin Amyloid Cardiomyopathy in Everyday Practice
16. Transthyretin Stabilization by AG10 in Symptomatic Transthyretin Amyloid Cardiomyopathy
17. Biomarkers as Predictors of Cardiac Toxicity From Targeted Cancer Therapies
18. Changing outcomes after heart transplantation in patients with amyloid cardiomyopathy
19. Cancer Therapy-Induced Left Ventricular Dysfunction: Interventions and Prognosis
20. Drug Development for Transthyretin Amyloidosis: Time to Fix the System?
21. Capecitabine-Induced Chest Pain Relieved by Diltiazem
22. Dipeptidyl Peptidase 4 Inhibition Increases Myocardial Glucose Uptake in Nonischemic Cardiomyopathy
23. Chemotherapy-Associated Cardiotoxicity: How Often Does it Really Occur and How Can it Be Prevented?
24. Generation of two induced pluripotent stem cell lines from hereditary amyloidosis patients with polyneuropathy carrying heterozygous transthyretin (TTR) mutation
25. Myocarditis Surveillance With High-Sensitivity Troponin I During Cancer Treatment With Immune Checkpoint Inhibitors
26. Heart Failure in Hispanics
27. Generation of two induced pluripotent stem cell lines from patients with cardiac amyloidosis carrying heterozygous transthyretin (TTR) mutation
28. Insulin-Resistant Cardiomyopathy: Clinical Evidence, Mechanisms, and Treatment Options
29. Management of Cardiac Amyloidosis: Do’s and Don’ts
30. Impact of Nesiritide on Renal Function in Patients With Acute Decompensated Heart Failure and Pre-Existing Renal Dysfunction: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
31. Cardiomyopathy of Insulin Resistance
32. ESC Cardio-Oncology Guidelines: A Triumph—But Are We Overscreening?
33. Insulin resistance in idiopathic dilated cardiomyopathy: A possible etiologic link
34. Constrictive Pericarditis Revealing Rare Case of ALH Amyloidosis With Underlying Lymphoplasmacytic Lymphoma (Waldenstrom Macroglobulinemia)
35. LATE ONSET IMMUNOTHERAPY-INDUCED MYOCARDITIS TWO YEARS AFTER CHECKPOINT INHIBITOR INITIATION
36. Daratumumab yields rapid and deep hematologic responses in patients with heavily pretreated AL amyloidosis
37. Global Longitudinal Strain in Cardio-Oncology
38. Reply: Should We Be for ASCT?: If Yes, Then When?
39. Bone Scintigraphy Imaging for Transthyretin Cardiac Amyloidosis: Still Much to Learn
40. Doxycycline and Ursodiol for ATTR Amyloidosis: Not Ready for Prime Time
41. Reply to “Heart Failure and Breast Cancer: Emerging Controversies Regarding Some Cardioprotective Strategies”
42. Chemotherapy-Induced Left Ventricular Dysfunction: Interventions and Prognosis
43. Therapy With a DPP-4 Inhibitor Increases Myocardial Glucose Uptake in Nonischemic Cardiomyopathy
44. Reply
45. Cardiac Amyloidosis: Screening Criteria for Heart Transplantation and New Strategies for Post-Transplant Therapy
46. Impedance Cardiography Is Superior to Echocardiographic Methods for Pacing Interval Optimization
47. Reply
48. High prevalence of impaired glucose metabolism in patients with idiopathic dilated cardiomyopathy
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.